Becton Dickinson (WBO:BDX) Cyclically Adjusted Revenue per Share: € (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:BDX Becton Dickinson & Co WBO:BDX
60 GF Score
Price €157.25
GF Value €157.86
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Becton Dickinson Cyclically Adjusted Revenue per Share?

Becton Dickinson WBO:BDX -1.32% 60 Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus rates WBO:BDX with a GF Score™ of 60/100 and a GF Value™ of €157.86 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Becton Dickinson's adjusted revenue per share for the three months ended in Jun. 2026 was €15.575. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, Becton Dickinson's average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Becton Dickinson was 9.30% per year. The lowest was 5.00% per year. And the median was 8.20% per year.

As of today (2026-09-20), Becton Dickinson's current stock price is €157.25. Becton Dickinson's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was . Becton Dickinson's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Becton Dickinson was 4.38. The lowest was 1.77. And the median was 3.29.


Becton Dickinson  (WBO:BDX) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Becton Dickinson was 4.38. The lowest was 1.77. And the median was 3.29.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Becton Dickinson Cyclically Adjusted Revenue per Share Related Terms


Becton Dickinson Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson Cyclically Adjusted Revenue per Share Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Becton Dickinson Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

WBO:BDX vs RMD, MDLN, WST: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Becton Dickinson's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's Cyclically Adjusted PS Ratio falls into.


WBO:BDX
60GF Score
Becton Dickinson & Co WBO:BDX
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Becton Dickinson's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=15.575/333.9520*333.9520
=15.575

Current CPI (Jun. 2026) = 333.9520.

Becton Dickinson Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 13.285 241.428 18.376
201612 12.445 241.432 17.214
201703 12.786 243.801 17.514
201706 12.490 244.955 17.028
201709 11.594 246.819 15.687
201712 11.372 246.524 15.405
201803 12.850 249.554 17.196
201806 13.108 251.989 17.372
201809 14.096 252.439 18.648
201812 13.293 251.233 17.670
201903 13.689 254.202 17.984
201906 14.112 256.143 18.399
201909 14.995 256.759 19.503
201912 13.879 256.974 18.037
202003 14.036 258.115 18.160
202006 12.277 257.797 15.904
202009 13.962 260.280 17.914
202012 15.210 260.474 19.501
202103 13.878 264.877 17.497
202106 13.102 271.696 16.104
202109 14.253 274.310 17.352
202112 14.396 278.802 17.244
202203 14.738 287.504 17.119
202206 15.158 296.311 17.084
202209 16.493 296.808 18.557
202212 15.766 296.797 17.740
202303 15.730 301.836 17.404
202306 15.565 305.109 17.036
202309 15.975 307.789 17.333
202312 15.021 306.746 16.353
202403 16.010 312.332 17.118
202406 15.969 314.175 16.974
202409 17.031 315.301 18.038
202412 16.684 315.605 17.654
202503 14.794 319.799 15.449
202506 14.517 322.561 15.030
202509 17.554 324.800 18.049
202512 15.786 324.054 16.268
202603 14.358 330.213 14.521
202606 15.575 333.952 15.575

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of € mean?
Becton Dickinson (WBO:BDX) has a Cyclically Adjusted Revenue per Share of € as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's Cyclically Adjusted Revenue per Share too high?
Becton Dickinson's current Cyclically Adjusted Revenue per Share is €. Overall, Becton Dickinson has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Cyclically Adjusted Revenue per Share compare to RMD and MDLN?
Becton Dickinson's Cyclically Adjusted Revenue per Share of € can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current Cyclically Adjusted Revenue per Share is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Based on GuruFocus' analysis, Becton Dickinson (WBO:BDX) is currently considered Fairly Valued. The stock's GF Value™ is €157.86, compared to a current price of €157.25 — trading 0.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €. Becton Dickinson's overall GF Score™ is 60/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Becton Dickinson (WBO:BDX), the current Cyclically Adjusted Revenue per Share is € as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (WBO:BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of €157.25 is trading 0.4% below its estimated GF Value™ of €157.86. GuruFocus considers Becton Dickinson to be Fairly Valued.

Key valuation signals for WBO:BDX:

  • Cyclically Adjusted Revenue per Share:
  • GF Value™: €157.86 vs. price of €157.25 (0.4% below fair value)
  • GF Score™: 60/100 with 7 warning signs

No single metric tells the full story. See the WBO:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
60GF Score

Get the complete analysis for WBO:BDX

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€157.25
Price
€157.86
GF Value